Non-Performing Assets / Total Loans: A classification used by financial institutions that refer to loans that are in jeopardy of default as a potion of total loans made. Calculated as: Non-Perfroming Assets / Gross Loans Made
Viracta Therapeutics, Inc. (VIRX) Non-Performing Assets / Total Loans data is not available.
| Income Statement Financials | |
-- |
|
$-10.55M |
|
-- |
|
-- |
|
$10.19M |
|
$-10.19M |
|
$-0.37M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.19M |
|
$-10.20M |
|
39.57M |
|
39.57M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$21.80M |
|
$0.11M |
|
$0.15M |
|
$21.96M |
|
$28.57M |
|
-- |
|
-- |
|
$28.57M |
|
$-6.62M |
|
$-6.62M |
|
$-6.62M |
|
39.74M |
|
| Cash Flow Statement Financials | |
$-24.77M |
|
$34.05M |
|
$-8.48M |
|
$12.32M |
|
$13.13M |
|
$0.81M |
|
$4.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
|
Non-Performing Assets / Total Loans |
-- |
-- |
|
-- |
|
-2.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
159.48% |
|
159.48% |
|
-48.06% |
|
159.48% |
|
$-0.17 |
|
$-0.63 |
|
$-0.63 |
|